Skip to main content
FinSpry Logo
FinSpry
DXCM logo
DXCM
(NASDAQ)
DexCom, Inc.
$71.44-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

DexCom (DXCM) Stock Price & Financial Analysis

DexCom Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$66.30 - $71.48
52-Week High$89.98
52-Week Low$54.11
Open$66.71
Volume11.20M
Average Volume (3M)5.98M
Market Cap26.35B
Shares Outstanding393.60M
P/E Ratio (TTM)28.32
Forward P/E17.76
Price to Sales (P/S)5.47
Price to Book (P/B)8.91
EV/EBITDA18.39
Revenue (TTM)4.82B
Net Income (TTM)930.40M
Free Cash Flow (TTM)1.43B
EPS (TTM)$2.31
Profit Margin19.31%
Operating Margin21.45%
Return on Equity (ROE)31.47%
Debt to Equity0.42
50-Day MA$64.01
200-Day MA$68.61
52-Week Change-30.24%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About DexCom

What is the current stock price for DXCM?

As of the latest trading session, DXCM stock trades at $71.44. The 52-week range is $54.11–$89.98, with a day range of $66.30–$71.48.

What is the P/E ratio for DXCM?

DexCom's trailing P/E ratio is 28.3, meaning investors pay $28.3 for every $1 of annual earnings. The forward P/E is 17.8, reflecting analyst expectations for future earnings.

Does DXCM pay dividends?

DexCom does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for DXCM?

Based on 2 analysts, the consensus for DXCM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of DXCM?

DexCom's market capitalization is $28.12B, classifying it as a large-cap company..